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Toll-like receptor 2 (TLR2) is the best-characterized pattern-recognition receptor for the
highly pathogenic intracellular bacterium, Francisella tularensis. We previously identified a
mutant in the live vaccine strain (LVS) of Francisella, LVS clpB, which is attenuated, but
induces a protective immune response. We sought to determine whether TLR2 signaling
was required during the immune response to LVS clpB. TLR2 knock-out (TLR2 KO) mice
previously infected with LVS clpB are completely protected during a lethal challenge with
LVS. Furthermore, the kinetics and magnitude of the primaryT-cell response in B6 andTLR2
KO mice are similar indicating that TLR2 signaling is dispensable for the adaptive immune
response to LVS clpB. TLR2 signaling was important, however, for the innate immune
response to LVS clpB. We identified three classes of cytokines/chemokines that differ in
their dependence on TLR2 signaling for production on day 3 post-inoculation in the bron-
choalveolar lavage fluid. IL-1α, IL-1β, IL-2, IL-17, MIP-1α, and TNF-α production depended on
TLR2 signaling, while GM-CSF, IFN-γ, and VEGF production were completely independent
of TLR2 signaling. IL-6, IL-12, IP-10, KC, and MIG production were partially dependent on
TLR2 signaling. Together our data indicate that the innate immune response to LVS clpB
requiresTLR2 signaling for the maximal innate response, whereasTLR2 is not required for
the adaptive immune response.
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INTRODUCTION
Germline-encoded pattern recognition receptors (PRRs) recog-
nize conserved microbial components and initiate innate immune
responses [reviewed in Ref. (1)]. Toll-like receptors (TLRs) are one
class of PRR. TLR2 is the best-characterized PRR for the highly
pathogenic, intracellular bacterium Francisella tularensis. TLR2
recognizes triacyl and diacyl lipoproteins when in complex with
TLR1 or TLR6, respectively. Three TLR2 ligands have been iden-
tified in Francisella: LpnA (also known as Tul4), FTT_1103, and
FTL_0645 (2–4). Ligand engagement of TLR2 leads to an associa-
tion between TLR2’s Toll/IL-1R intracellular domain and MyD88
(5). MyD88 then recruits and activates IL-1 receptor-associated
kinase 4 and TNFR-associated factor 6, which leads to downstream
NF-κB activation and finally pro-inflammatory cytokine produc-
tion (5). TLR2 knock-out (TLR2 KO) mice are more suscepti-
ble to wild-type Francisella with increased bacterial burdens and
decreased mean time to death (6, 7). The increased susceptibility
of TLR2 KO mice is likely due to the requirement for TLR2 sig-
naling during the innate immune response to Francisella (6–13).
For example, TLR2 KO peritoneal macrophages or bone marrow-
derived dendritic cells (DCs) fail to make pro-inflammatory
cytokines such as TNF-α, IL-12, and IL-6 (7, 8, 10).
One hallmark of pneumonic tularemia caused by wild-type
Francisella is the near absence of an innate immune response in the
lung despite high bacterial burdens (14). An in-frame deletion of
the clpB gene in the live vaccine strain (LVS) of F. tularensis subsp.
holartica results in bacteria that lack the ability to inhibit host
innate immune (15). ClpB is a highly conserved chaperone pro-
tein of the AAA+ superfamily of ATPases, which mediate protein
disaggregation (16). ClpB has not been shown to be a TLR2 ligand,
nor has it been shown to affect the expression of identified TLR2
ligands (17). Intranasal inoculation of C57Bl/6J and BALB/cJ mice
with LVS clpB significantly increases the concentration of pro-
inflammatory cytokines and chemokines in the bronchoalveolar
lavage fluid (BALF) 3 days post-inoculation compared to LVS inoc-
ulated mice (15). Despite a robust innate immune response during
LVS clpB infection, adaptive immunity is required for bacterial
clearance and the frequency of IFN-γ producing CD4+ and CD8+
T-cells is similar in mice inoculated with LVS or LVS clpB (15). We
and others have demonstrated that vaccination with clpB mutants
in both LVS and the highly virulent F. tularensis subspecies tularen-
sis (SchuS4) provide protection during lethal, wild-type challenge
(15, 17–19).
Due to the well-characterized role of TLR2 during the immune
response to wild-type Francisella, we sought to determine whether
TLR2 was required during the immune response to LVS clpB.
TLR2 KO mice were able to clear LVS clpB; clearance, however, was
delayed compared to B6 mice inoculated with LVS clpB. Addition-
ally, TLR2 KO mice previously infected with LVS clpB survived
lethal LVS challenge. The ability of TLR2 KO mice to survive a
lethal secondary challenge was not surprising given that the T-cell
response in B6 and TLR2 KO mice was similar on days 7 and
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10 post-inoculation during the primary infection. Together, these
data indicated that TLR2 signaling is dispensable during the pri-
mary and secondary T-cell response. However, TLR2 signaling was
required for the maximal innate immune response to LVS clpB. We
identified three classes of cytokines and chemokines in the BALF
that differed in their requirement of TLR2 signaling for production
on day 3 post-inoculation (TLR2 independent, TLR2 dependent,
and TLR2 partially dependent). Together, these data indicated that
while TLR2 is critical during the innate immune response, TLR2
signaling is dispensable during the primary adaptive immune
response and a secondary challenge.
MATERIALS AND METHODS
BACTERIA
Francisella tularensis subspecies holarctica LVS with an in-frame
deletion of clpB (FTL_0094) was generated as previously described
(15). Wild-type LVS was obtained from the CDC (Atlanta, GA,
USA). Bacteria were grown at 37°C on chocolate agar supple-
mented with 1% IsoVitalex (Becton-Dickinson). Bacterial inoc-
ulations were prepared by re-suspending bacteria from a lawn
grown on chocolate agar in sterile PBS at an OD600= 1 (equiv-
alent to 1× 1010 CFU/mL). The number of viable bacteria was
determined by serial dilution and plating on chocolate agar.
MICE
C57Bl/6J (B6) and B6.SJL-PtprcaPepcb/BoyJ (B6-CD45.1), and
B6.129-Tlr2tm1Kir/J (TLR2 KO) mice were obtained from The Jack-
son Laboratory (Bar Harbor, ME, USA). TLR2 KO mice were bred
in-house and were age-matched with vendor-purchased B6 mice.
Female B6 and TLR2 KO mice were between 6 and 10 weeks old at
the time of inoculation. All mice were housed in specific pathogen-
free conditions at the University of Arizona in accordance with the
Institutional Animal Care and Use Committee (IACUC).
INOCULATION OF MICE
Mice were anesthetized with 575 mg/kg tribromomethanol
(Sigma) and intranasally inoculated with 5× 104 CFU LVS clpB.
For lethal LVS challenge experiments, mice were anesthetized
with 0.25 mL of 7.5 mg/mL ketamine and 0.5 mg/mL xylazine
cocktail in PBS and intranasally inoculated with 5× 103 CFU
(5× LD50) LVS 35 days after the initial sub-lethal infection. Mice
were weighed daily and sacrificed if they lost more than 25% of
their starting weight.
BACTERIAL BURDEN DETERMINATION
Spleen, liver, and lung tissue were homogenized in sterile PBS
using a Biojector (Bioject). Ten-fold serial dilutions of tissue
homogenates were made using PBS and plated on chocolate agar.
Resulting colonies were counted 72 h later. The limit of detection
is 50 colony forming units (CFU) per organ.
SPLEEN, LUNG, AND BRONCHOALVEOLAR LAVAGE CELL ISOLATION
Spleens and lungs were harvested from mice and processed into
single-cell suspensions as previously described (15). BALF was col-
lected as previously described (15). Cells were removed from the
BALF using centrifugation and resulting supernatant was stored
at−80°C for multiplex cytokine/chemokine profiling.
ANTIBODIES
The following directly conjugated antibodies were used for analyz-
ing cells in the BALF: CD3 Pacific Blue (17A2; Biolegend), CD11b
V500 (M1/70; BD), CD11c PE-Cy7 (N418; Biolegend), CD19
PerCP-Cy5.5 (6D5; Biolegend), F4/80 PE (BM8; Biolegend), and
GR-1 AF700 (RB6-8C5; Biolegend). BALF cells were stained with
10µg/mL AF350 succimidyl ester (Life Technologies) to distin-
guish live and dead cells prior to staining with surface antibodies.
Antibodies used for intracellular cytokine staining (ICS) were the
same as previously described (15).
CYTOKINE/CHEMOKINE QUANTIFICATION
A multiplex luminex bead-based approach was used to quantify
cytokines/chemokines in the BALF as described (15). A 20-analyte
assay panel was performed according to the manufacturer’s pro-
tocol (Life Technologies) using a BioPlex array reader (Bio-Rad
Laboratories) in the Duke Regional Biocontainment Laboratory
Immunology Unit (Durhan, NC, USA).
INTRACELLULAR CYTOKINE STAINING
Intracellular cytokine staining was performed as previously
described (15). Briefly, B6-CD45.1 splenocytes were inoculated
with LVS at an MOI of 200:1. Two hours post-inoculation, cells
were washed and fresh medium containing 5µg/mL gentamicin
(Sigma) was added. Infected splenocytes were incubated overnight
in the presence of gentamicin. Infected splenocytes were washed
extensively and then cultured at a 1:1 ratio with cells isolated from
the spleen and lung of infected mice for 24 h. A total of 10µg/mL
Brefeldin A (Sigma) was added during the last 4 h of culture to
stop cytokine secretion. Flow cytometry data were analyzed as
previously described using FlowJo v10.0.6 (Treestar) (15).
STATISTICAL ANALYSIS
A one-way ANOVA with Tukey’s post-test was used for BALF
cytokine and chemokine concentrations. A Mann–Whitney test
was used for ICS data to compare B6 and TLR2 KO mice on days
0, 7, or 10 post-inoculation. Bacterial burdens were log trans-
formed and then a Student’s t -test was applied. GraphPad Prism
(v5.04) was used for analysis. Significance levels are indicated in
the figures as follows: *P < 0.05, **P < 0.01, ***P < 0.001, and
****P < 0.0001.
RESULTS
TLR2 KO AND B6 MICE HAVE DIFFERENT DISEASE COURSES WHEN
INOCULATED WITH LVS clpB
B6 mice clear LVS clpB infection by day 10 post-inoculation (15).
We first sought to determine whether disease course and bac-
terial clearance were altered in TLR2 KO mice inoculated with
LVS clpB. B6 or TLR2 KO mice were intranasally inoculated with
5× 104 CFU LVS clpB and then sacrificed on days 3, 7, 10, or 14
post-inoculation to determine bacterial burdens. Weight loss pro-
files in B6 and TLR2 KO mice inoculated with LVS clpB differed
in peak weight loss (−12% in B6 and−7% in TLR2 KO) and rate
of weight gain after day 5 post-inoculation (Figure 1A). Although
peak bacteremia was the same in B6 and TLR2 KO mice (day 3
post-inoculation), LVS clpB clearance was delayed in the spleen,
liver, and lung of TLR2 KO mice (Figures 1B–D). All B6 mice
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FIGURE 1 | LVS clpB clearance is delayed inTLR2 KO mice. B6 or
TLR2 KO mice were intranasally inoculated with 5×104 CFU LVS clpB.
(A) Mice were weighed daily and weight loss is reported as a percentage
of starting weight. Mice were sacrificed on days 3, 7, 10, and 14
post-inoculation and bacterial burdens were determined in the
(B) spleen, (C) liver, and (D) lung. The dashed line indicates the limit of
detection of 50 CFU per organ. Data are combined from two
experiments per time point. n= 7–10 mice/group. Bacterial burdens
were log transformed and then a Student’s t -test was used to determine
statistical significance.
cleared LVS clpB by day 14 post-inoculation, whereas only 4 out of
10 TLR2 KO mice had completely cleared LVS clpB. The remain-
ing six TLR2 KO mice had low detectable levels of bacteria in the
spleen and lung (Figures 1B,D).
LVS clpB VACCINATION OF TLR2 KO MICE PROTECTS AGAINST LETHAL
LVS CHALLENGE
Prior infection (i.e., vaccination) with LVS clpB protects B6 mice
during a lethal LVS challenge (15, 20). We therefore sought to
determine whether TLR2 was required for protection during a
secondary challenge. B6 and TLR2 KO mice were challenged with
a lethal dose of LVS 35 days after inoculation with LVS clpB. 100%
of the B6 and TLR2 KO mice previously inoculated with LVS clpB
survived the LVS lethal dose challenge, whereas all naïve mice suc-
cumbed to infection (Figure 2A). Vaccinated B6 and TLR2 KO
mice also had similar weight loss profiles during lethal challenge
(Figure 2B). Peak weight loss in both groups occurred on day
3 post-rechallenge and was approximately −8% of the starting
weight in both groups (Figure 2B). The weight loss curve for naïve
TLR2 KO mice has increased variability because not all mice lost
>25% of their starting weight on the same day post-inoculation
(Figure 2B). When vaccinated B6 and TLR2 KO mice were sac-
rificed on day 14 post-rechallenge, no culturable bacteria were
present in the spleen, liver, or lung (data not shown), indicat-
ing that vaccination with LVS clpB provided sterilizing immunity
during LVS rechallenge and that TLR2 signaling was not required
during this memory response.
THE T-CELL RESPONSE IN THE LUNG IS SIMILAR IN B6 AND TLR2 KO
MICE INOCULATED WITH LVS clpB
The ability of TLR2 KO mice to survive a lethal LVS challenge
suggested that TLR2-deficient mice are able to mount an effective
T-cell response to LVS clpB. To determine whether the absence of
TLR2 signaling affected the kinetics or magnitude of the T-cell
response, we used ICS to enumerate three T-cells subsets (IFN-γ+
CD4+ (Th1), IL-17A+ CD4+ (Th17), and IFN-γ+ CD8+ cyto-
toxic T-cell) on days 7 and 10 post-inoculation. TLR2 KO mice
had a significant increase in lung cellularity compared to B6 mice
on day 10, but not day 7, post-inoculation (Figure 3A). The dif-
ference observed on day 10 is likely due to the presence of bacteria
in TLR2 KO, but not B6 mice. There was no difference in the
absolute number of Th1 cells or percentage of IFN-γ+/CD4+ T-
cells in the lungs of LVS clpB inoculated B6 or TLR2 KO mice
(Figures 3B,C). There was also no difference in the absolute num-
ber of Th17 cells in the lung of B6 and TLR2 KO mice or percentage
of IL-17A+/CD4+ T-cells (Figures 3D,E). Finally, there was no
difference in the absolute number of IFN-γ+ CD8+ T-cells or
percentage of IFN-γ+/CD8+ T-cells in B6 or TLR2 KO mice inoc-
ulated with LVS clpB (Figures 3F,G). Together, these data indicate
that the kinetics and magnitude of the T-cell response in the lung
during LVS clpB infection is similar in B6 and TLR2 KO mice sug-
gesting that TLR2 signaling is not required to mount an adaptive
immune response to LVS clpB.
THE T-CELL RESPONSE IN THE SPLEEN IS SIMILAR IN B6 AND TLR2 KO
MICE INOCULATED WITH LVS clpB
In addition, we used ICS to identify Th1, Th17, and IFN-γ+ CD8+
T-cells in the spleen on days 7 and 10 post-inoculation. There
was no difference in total spleen cellularity in B6 and TLR2 KO
mice inoculated with LVS clpB (Figure 4A). There were also no
significant differences in the absolute number or percentage of
cytokine positive Th1, Th17, or IFN-γ+ CD8+ T-cell subsets in
LVS clpB inoculated B6 or TLR2 KO mice (Figures 4B–G). These
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FIGURE 2 |TLR2 KO previously inoculated with LVS clpB survive a
lethal LVS challenge. B6 or TLR2 KO mice were intranasally inoculated
with 5×104 CFU LVS clpB or were left naive. Thirty-five days later, mice
were intranasally challenged with 5×103 CFU LVS and (A) survival was
determined. (B) Mice were weighed daily and weight loss is reported as a
percentage of starting weight. Data are combined from two independent
experiments. n=6–10 mice/group.
data indicate that like the lung, the kinetics and magnitude T-cell
response in the spleen is similar in B6 and TLR2 KO mice, suggest-
ing that TLR2 signaling is dispensable for the adaptive immune
response to LVS clpB.
CYTOKINE AND CHEMOKINE PRODUCTION FOLLOWING LVS clpB
INOCULATION HAVE DIFFERENTIAL REQUIREMENTS FOR TLR2
SIGNALING
Although TLR2 appears to be dispensable for the adaptive immune
response to LVS clpB, we sought to determine whether the innate
immune response required TLR2 signaling for maximal cytokine
and chemokine production. If so, we can use LVS clpB to iden-
tify host signaling pathways that are altered during LVS infection,
and interrogate the requirement of signaling moieties for the
production of specific cytokines and chemokines. Three days post-
inoculation with LVS clpB, mice were sacrificed and the BALF
was collected. The concentration of 20 different cytokines and
chemokines in the BALF was determined using a multiplex bead
assay and data reported as fold-change (Figure 5). The absolute
concentrations of the cytokines and chemokines are listed in Table
S1 in Supplementary Material.
We identified three classes of clusters and chemokines: those
that were partially dependent on TLR2, those that were dependent
on TLR2, and those that were independent of TLR2. Cytokines
and chemokines that partially depended on TLR2 signaling for
their production are IL-6, IL-12 (p40/p70), KC, MIG, and IP-10.
Cytokines and chemokines that depended on TLR2 signaling for
their production (i.e., are not made at increased levels in infected
TLR2 KO compared to uninfected mice) were IL-1α, IL-1β, IL-2,
IL-17, MIP-1α, and TNF-α. GM-CSF, IFN-γ, and VEGF were made
at similar levels in B6 and TLR2 KO mice indicating that their pro-
duction was independent of TLR2 signaling. These data indicated
that while TLR2 signaling is responsible for the induction of some
cytokines and chemokines, other innate signaling molecules may
also contribute to the overall innate response to infection.
TLR2 IS REQUIRED FOR MAXIMAL CELLULAR INFILTRATION INTO
BRONCHOALVEOLAR LAVAGE FLUID
We speculated that the differences observed in BALF
cytokine/chemokine milieu between LVS clpB inoculated B6 and
TLR2 KO mice could impact airspace infiltration by innate
immune cells. We therefore used flow cytometry to identify
immune cell subsets within the BALF on day 3 post-inoculation.
TLR2 KO mice have decreased BALF cellularity compared to B6
mice (Figure 6A). When the cellular composition of the BALF was
compared, TLR2 KO mice had fewer neutrophils as a percentage
of live cells compared to B6 mice (Figure 6B). TLR2 KO mice had
an increased percentage of DCs compared to B6 mice (Figure 6C).
There was no difference in the percentage of alveolar macrophages
(AMs) or interstitial macrophages (IMs) when LVS clpB inoculated
B6 and TLR2 KO mice were compared (Figures 6D,E). There was,
however, a significant decrease in the frequency of AMs in the
BALF of infected animals compared to uninfected control mice
(Figure 6D). The frequency of AMs changed in B6 and TLR2
KO mice inoculated with LVS clpB because there was an influx of
infiltrating neutrophils. When the total number of AMs was com-
pared in uninfected or B6 and TLR2 KO mice inoculated with LVS
clpB, we did not observe any significant differences between groups
(data not shown). Together, these data indicated that differences
in the BALF cytokine/chemokine milieu in TLR2 KO mice cor-
relate with changes in BALF cellular composition. Furthermore,
these data in conjunction with BALF cytokine and chemokine pro-
files suggested that TLR2 signaling is required during the innate
immune response to LVS clpB.
DISCUSSION
Pattern-recognition receptors, such as TLRs, play a critical role
in initiating an innate immune response to microbial pathogens.
TLRs except TLR3 and TLR4 require the adaptor protein MyD88
for signaling (5). MyD88-deficient mice are highly susceptible
to Francisella infection indicating PRRs are critical to the host’s
immune response during infection (21). The role of several TLRs
has been studied in the context of a Francisella infection. Although
Francisella is a gram-negative pathogen, it has an altered lipid A
structure that fails to induce signaling through TLR4 (22–25).
TLR4 knock-out (TLR4 KO) mice are not more susceptible than
wild-type mice to Francisella infection (7, 26, 27). The importance
of TLR5 and TLR9 has also been tested in the context of Fran-
cisella infection, but no phenotype was observed for either PRR
(9, 21). To date, TLR2 is the best-characterized PRR for F. tularen-
sis (6–13). Pro-inflammatory cytokine production requires TLR2
signaling and TLR2 KO mice are more susceptible to sub-lethal
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FIGURE 3 |TLR2 signaling is not required for theT-cell response in the
lung. B6 or TLR2 KO mice were intranasally inoculated with 5×104 CFU
LVS clpB or were left naive. On days 7 and 10 post-inoculation, mice were
sacrificed and lungs were removed and digested into a single-cell
suspension. (A) The total number of cells in the lung was determined by
trypan blue exclusion. Lung cells were re-stimulated with LVS-infected
CD45.1 splenocytes for 24 h. Brefeldin A was added during the last 4 h of
culture. Flow cytometry was used to determine the (B) total number of
CD4+ IFN-γ+ T-cells, (C) % IFN-γ+ of CD4+ T-cells, (D) total number of
CD4+ IL-17A+ T-cells, (E) % IL-17A+ of CD4+ T-cells, (F) total number of
CD8+ IFN-γ+ T-cells, and (G) % IFN-γ+ of CD8+ T-cells. Data are combined
from at least two independent experiments per time point. n= 4–6
mice/group. Statistical significance was determined using a
Mann–Whitney test for each time point.
infection with LVS (6–10). In order to evade the TLR2-mediated
host immune response, Francisella actively inhibits the early innate
immune response in vivo (14, 15). Lipids derived from SchuS4
inhibit E. coli LPS-induced TNF-α and IL-6 production in the
lungs of B6 mice, but not TLR2 KO mice indicating that the
lipids depend on TLR2 signaling to inhibit the pro-inflammatory
response (12). Not only does Francisella directly inhibit host sig-
naling via TLR2, it also uses the CRISPR/Cas system to regulate
expression of its own bacterial lipoprotein (FTN_1103) that could
be sensed by host TLR2 (28).
We have previously shown that LVS clpB fails to inhibit the
early innate immune response and unlike inoculation with wild-
type LVS, a robust pro-inflammatory innate immune response
is detected in the BALF on day 3 post-inoculation (15). Despite
LVS clpB’s attenuation, it elicits a robust T-cell response and pre-
vious infection with LVS clpB protects 100% of mice challenged
with a lethal dose of LVS (15, 20). We were therefore interested
in whether TLR2, a key host sensor for detecting Francisella, was
required during the various phases of the immune response to
LVS clpB.
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FIGURE 4 |TLR2 signaling is not required for theT-cell response in the
spleen. B6 or TLR2 KO mice were intranasally inoculated with 5×104 CFU
LVS clpB or were left naive. On days 7 and 10 post-inoculation, mice were
sacrificed and spleens were removed and processed into a single-cell
suspension. (A) The total number of cells in the spleen was determined by
trypan blue exclusion. Spleen cells were re-stimulated with LVS-infected
CD45.1 splenocytes for 24 h. Brefeldin A was added during the last 4 h of
culture. Flow cytometry was used to determine the (B) total number of
CD4+ IFN-γ+ T-cells, (C) % IFN-γ+ of CD4+ T-cells, (D) total number of CD4+
IL-17A+ T-cells, (E) % IL-17A+ of CD4+ T-cells, (F) total number of CD8+
IFN-γ+ T-cells, and (G) % IFN-γ+ of CD8+ T-cells. Data are combined from at
least two independent experiments per time point. n=4–6 mice/group.
Statistical significance was determined using a Mann–Whitney test for each
time point.
Toll-like receptor 2 KO mice exhibited delayed clearance of
LVS clpB (Figure 1). B6 and TLR2 KO mice had similar peak
lung bacterial burdens on day 3 post-inoculation indicating that
the delayed clearance was not simply due to an initial increase
in bacterial burdens that persists during the course of infection.
One possible explanation for the delayed clearance is a delay in
the T-cell response in TLR2 KO mice. TLR2 has been shown to
be required for CD80, CD86, and MHCII up-regulation in bone
marrow-derived DCs inoculated with LVS (8). We did not observe
any defects in the T-cell response in TLR2 KO mice on days 7
or 10 post-inoculation, suggesting that a poor T-cell response
was not the cause of the delayed bacterial clearance in TLR2 KO
mice. Another possible explanation for delayed clearance in TLR2
KO mice is the requirement of both IFN-γ and TNF-α during
Francisella infection (29–31). Production of IFN-γ during the
innate immune response against LVS clpB was completely inde-
pendent of TLR2 signaling (Figure 5). Likewise, TLR2 KO mice
intranasally inoculated with wild-type LVS produce significantly
more IFN-γ on day 7 post-inoculation compared to B6 mice indi-
cating that TLR2 is not required for IFN-γ production (6). TNF-α
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FIGURE 5 |TLR2 signaling is required for maximal cytokine and
chemokine production in the lung after LVS clpB inoculation. B6 or
TLR2 KO mice were intranasally inoculated with 5×104 CFU LVS clpB or
were left naive. Three days post-inoculation, mice were sacrificed and BALF
was collected, and cytokine and chemokine concentrations were
determined using a Luminex-based assay. For each pair of groups, a
fold-changed was determined based on the average cytokine or chemokine
concentrations. Data are combined from two independent experiments.
n=7–12 mice/group. Statistical significance was determined using ANOVA
with Tukey’s post-test on the absolute concentration of each analyte.
production after LVS clpB inoculation, however, required TLR2
signaling (Figure 5). TNF-α production in the lungs of TLR2 KO
mice inoculated with LVS is delayed and the overall concentra-
tion of TNF-α is lower when measured in lung homogenate or
by in situ TNF-α staining (6, 7). Together, these data indicate that
while the IFN-γ-mediated immune response is intact in TLR2
KO mice, there could be defects in the TNF-α-mediated response,
which results in delayed LVS clpB clearance.
The ability of TLR2 KO mice to survive a lethal LVS secondary
challenge suggested that these mice mount a robust adaptive
immune response since T-cells are required for survival during a
secondary infection (32). Indeed, B6 and TLR2 KO mice had sim-
ilar absolute numbers and frequencies of Th1, Th17, and CD8+
IFN-γ+ T-cells in the lung and spleen (Figures 3 and 4) on days
7 and 10 post-inoculation. Our data suggest that TLR2 signal-
ing did not affect the T-cell response during infection with LVS
clpB. In other infection models, TLR2 KO mice have decreased
T-cell responses. For example, when TLR2 KO T-cells are adop-
tively transferred into wild-type recipients, CD8+ T-cells undergo
decreased clonal expansion and failed to develop into long-lived
memory cells upon vaccina infection (33). In this model, T-
cells lacked TLR2 signaling, indicating that TLR2 signaling on
T-cells is important during vaccina infection. Although Quigley
et al. demonstrated that TLR2 deficiency on T-cell was impor-
tant, defects in the adaptive immune response observed in the
absence of TLR signaling are often attributed to defective antigen
presenting cells (34–37). In our model, TLR2 KO mice produce
significantly less IL-12, a cytokine required for the polarization of
Th1 cells, compared to B6 mice (38). Despite this defect or other
defects in TLR2-deficient antigen presenting cells that we did not
investigate, the T-cell response in TLR2 KO mice is very similar
to the response in B6 mice were TLR2 signaling is intact indicat-
ing that TLR2 is dispensable for the adaptive immune response to
LVS clpB.
We next investigated the requirement of TLR2 during the innate
immune response to LVS clpB. Because LVS clpB fails to inhibit the
early innate immune response (15), we could use LVS clpB as a tool
to identify host signaling pathways that are inhibited during wild-
type infection. Intranasal inoculation of B6 and TLR2 KO mice
with LVS clpB followed by collection of the BALF 3 days post-
inoculation, revealed three groups of cytokine and chemokine
production: dependent on TLR2, independent of TLR2, and par-
tially dependent on TLR2 (Figure 5). IL-1α, IL-1β, IL-2, IL-17,
MIP-1α, and TNF-αproduction required TLR2 signaling. Notably,
the failure of TLR2 KO mice to produce IL-1β suggests that TLR2
signaling provides the first signal that leads to up-regulation of
pro-IL-1β mRNA, which is later cleaved by active caspase-1. The
requirement of TLR2 signaling for mouse IL-1β production was
also demonstrated by Li et al. (9). GM-CSF, IFN-γ, and VEGF pro-
duction was independent of TLR2 signaling. IL-6, IL-12p40/p70,
KC, MIG, and IP-10 were partially dependent on TLR2 signaling.
The decreased frequency of neutrophils in the BALF of TLR2 KO
mice (Figure 6B) is likely a consequence of less KC (CXCL1) as
KC is a chemoattractant for neutrophils (39). TLR2 KO mice pro-
duced cytokines that have been shown to be important during
LVS infection such as IFN-γ, IL-6, and IL-12 (29–31, 40, 41). The
ability of TLR2 KO mice to produce these cytokines, even if at
reduced levels compared to B6 mice, indicates that infection with
wild-type LVS inhibits other immune signaling pathways in addi-
tion to TLR2. The identities of these host sensor(s) are currently
unknown.
Overall, we have demonstrated a differential requirement for
TLR2 signaling during the innate and adaptive immune response
to LVS clpB. The T-cell response was similar in B6 and TLR2 KO
mice indicating that the adaptive immune response during LVS
clpB infection does not require TLR2 signaling. TLR2 KO mice also
survived a secondary lethal challenge with LVS when first infected
with LVS clpB indicating that TLR2 is dispensable during the sec-
ondary response. Importantly, some cytokines and chemokines
were produced in TLR2 KO mice indicating that other signaling
pathways are also inhibited during wild-type Francisella infection
in addition to TLR2. The identities of these pathways are currently
unknown, but are a focus of our ongoing research. Together, we
have demonstrated that TLR2 is critical during the innate immune
response to LVS clpB but is not required during the primary or
secondary adaptive immune response.
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